Cooperman Leon G’s DiaMedica Therapeutics DMAC Stock Holding History

Cooperman Leon G’s Portfolio DMAC Stock Details DMAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$13.7M	Hold	2,020,000	–	–	0.45%	30
2025 Q4	$16.1M	Sell	2,020,000 -1,249,761	-38%	-$9.35M	0.53%	30
2025 Q3	$17.6M	Buy	3,269,761 +1,619,761	+98%	+$8.79M	0.55%	30
2025 Q2	$6.43M	Buy	1,650,000 +25,000	+2%	+$97.5K	0.23%	31
2025 Q1	$6.16M	Hold	1,625,000	–	–	0.24%	30
2024 Q4	$8.82M	Buy	1,625,000 +113,261	+7%	+$534K	0.33%	30
2024 Q3	$6.33M	Buy	1,511,739 +111,739	+8%	+$413K	0.27%	29
2024 Q2	$4.13M	Buy	1,400,000 +516,377	+58%	+$1.42M	0.17%	32
2024 Q1	$2.45M	Hold	883,623	–	–	0.1%	36
2023 Q4	$2.51M	Buy	883,623 +7,630	+0.9%	+$18.9K	0.12%	36
2023 Q3	$2.26M	Hold	875,993	–	–	0.12%	38
2023 Q2	$3.78M	Buy	875,993 +7,580	+0.9%	+$18.4K	0.21%	34
2023 Q1	$1.33M	Buy	868,413 +55,905	+7%	+$88.7K	0.08%	39
2022 Q4	$1.28M	Hold	812,508	–	–	0.08%	40
2022 Q3	$1.01M	Hold	812,508	–	–	0.07%	41
2022 Q2	$1.64M	Hold	812,508	–	–	0.11%	38
2022 Q1	$2.03M	Buy	812,508 +512,508	+171%	+$1.45M	0.11%	41
2021 Q4	$1.12M	Buy	300,000 +100,000	+50%	+$393K	0.06%	49
2021 Q3	$802K	Buy	200,000 +150,000	+300%	+$574K	0.04%	50
2021 Q2	$223K	Hold	50,000	–	–	0.01%	62
2021 Q1	$458K	Buy	50,000 +20,000	+67%	+$187K	0.03%	45
2020 Q4	$304K	Buy	+30,000	New	+$164K	0.02%	43

Other funds holding DMAC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PAPAIJV

Paragon Associates & Paragon Associates II Joint Venture Dallas, Texas $73.6M AUM 61.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Cooperman Leon G's DMAC Position: Q1 2026 in Review

Cooperman Leon G held its DiaMedica Therapeutics (DMAC) position steady in Q1 2026 at 2,020,000 shares worth $13.7M. The position accounts for 0.45% of the portfolio, ranked #30.

Cooperman Leon G first reported a position in DMAC in Q4 2020 and has held it in 22 quarters since. The position peaked at $17.6M in Q3 2025. 98 funds tracked by Wall St. Rank hold DMAC as of Q1 2026.

Cooperman Leon G held 2,020,000 shares of DiaMedica Therapeutics worth $13.7M as of Q1 2026.
Cooperman Leon G left its DiaMedica Therapeutics share count unchanged in Q1 2026.
DiaMedica Therapeutics made up 0.45% of Cooperman Leon G's portfolio in Q1 2026, its #30 holding.
Cooperman Leon G first reported a position in DiaMedica Therapeutics in Q4 2020 and has held it in 22 quarters since.
Cooperman Leon G's DiaMedica Therapeutics position peaked at $17.6M in Q3 2025.
98 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q1 2026.

Based on Cooperman Leon G's 13F filing for Q1 2026, filed 15 May 2026.